Hui Wang

14.7k total citations · 2 hit papers
267 papers, 8.7k citations indexed

About

Hui Wang is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Hui Wang has authored 267 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Molecular Biology, 64 papers in Cancer Research and 55 papers in Pathology and Forensic Medicine. Recurrent topics in Hui Wang's work include Cancer-related molecular mechanisms research (37 papers), RNA modifications and cancer (33 papers) and Circular RNAs in diseases (19 papers). Hui Wang is often cited by papers focused on Cancer-related molecular mechanisms research (37 papers), RNA modifications and cancer (33 papers) and Circular RNAs in diseases (19 papers). Hui Wang collaborates with scholars based in China, United States and France. Hui Wang's co-authors include Jingquan Li, Peizhan Chen, Qian Ba, Dong Xie, Haiyun Song, Ruiai Chu, Xiaoguang Li, Wenbo Yao, Mian Li and Ruiwen Zhang and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Hui Wang

254 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma

2015 585 citations Xiaoguang Li, Jingquan Li et al. Gut profile →
STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4

2017 436 citations Hui Wang, Xin‐Rong Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui Wang China	50	4.1k	2.2k	1.5k	1.3k	1.1k	267	8.7k
Jing Shen China	51	4.5k 1.1×	1.8k 0.8×	1.7k 1.2×	666 0.5×	1.2k 1.1×	277	8.2k
Amir Avan Iran	50	4.6k 1.1×	2.4k 1.1×	1.9k 1.3×	899 0.7×	798 0.7×	344	9.1k
Ming‐Feng Hou Taiwan	52	4.5k 1.1×	2.4k 1.1×	2.7k 1.9×	754 0.6×	1.0k 0.9×	410	10.4k
Frank Arfuso Australia	56	5.5k 1.4×	1.7k 0.8×	1.8k 1.2×	775 0.6×	754 0.7×	131	10.2k
Jie Jin China	43	4.0k 1.0×	1.3k 0.6×	1.5k 1.0×	1.0k 0.8×	780 0.7×	593	8.5k
Ioana Berindan‐Neagoe Romania	52	5.6k 1.4×	3.7k 1.7×	1.1k 0.8×	591 0.5×	727 0.6×	351	9.3k
Rohit Srivastava United States	61	7.3k 1.8×	1.8k 0.8×	2.6k 1.8×	1.3k 1.1×	1.3k 1.1×	206	12.0k
Shuang Chen China	49	6.5k 1.6×	1.9k 0.9×	1.6k 1.1×	440 0.4×	1.8k 1.5×	428	11.1k
Jack L. Arbiser United States	62	5.6k 1.4×	1.5k 0.7×	2.3k 1.6×	664 0.5×	1.7k 1.5×	246	12.6k
Bin Li China	50	6.6k 1.6×	3.2k 1.4×	2.1k 1.5×	618 0.5×	924 0.8×	394	10.3k

Countries citing papers authored by Hui Wang

Since Specialization

Citations

This map shows the geographic impact of Hui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Wang more than expected).

Fields of papers citing papers by Hui Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Wang. The network helps show where Hui Wang may publish in the future.

Co-authorship network of co-authors of Hui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Wang. A scholar is included among the top collaborators of Hui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Wang. Hui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hui, et al.. (2026). Transgenic expression of human CD47 on pig cells provides only partial protection against human macrophage-mediated destruction in human immune system mice. American Journal of Transplantation.

Liu, Wei, et al.. (2025). Co-occurrence and risk emission potential of antibiotics, antibiotic resistance genes, and heavy metals in concentrated leachate in China. Waste Management. 201. 114797–114797.

Qian, Hui, Yuxuan Wang, Xibin Zhou, et al.. (2025). ESM-Ezy: a deep learning strategy for the mining of novel multicopper oxidases with superior properties. Nature Communications. 16(1). 3274–3274. 8 indexed citations

Zhang, Tong, Dingguo Zhang, Jing Jin, Patrick P. Mercier, & Hui Wang. (2024). Design and Analysis of a Family of pW-Level Sub-1V CMOS VRGs by Stacking a Current-Source Transistor and a Resistive-Load Transistor. 1–5. 1 indexed citations

Wang, Hui, et al.. (2024). Identification and validation of an m7G-related lncRNAs signature for predicting prognosis, immune response and therapy landscapes in ovarian cancer. Frontiers in Genetics. 15. 1466422–1466422. 1 indexed citations

Yang, Yang, Xiaolin Hu, Jie Yuan, et al.. (2024). Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A⁺ myeloid cells to promote liver cancer progression. Gut. 74(2). 255–269. 28 indexed citations

Wang, Hui, Caiyun Nie, Huifang Lv, et al.. (2023). Novel GSH-responsive prodrugs derived from indole-chalcone and camptothecin trigger apoptosis and autophagy in colon cancer. Bioorganic Chemistry. 143. 107056–107056. 11 indexed citations

Wang, Hui, et al.. (2023). Analysis on the risk of myasthenia gravis related to immune checkpoint inhibitors based on the US FDA Adverse Event Reporting System. Cancer Medicine. 12(19). 19491–19499. 7 indexed citations

Liu, Feng, Hui Wang, Chao Jiang, et al.. (2023). Efficacy and Toxicity of Different Target Volume Delineations of Radiotherapy Based on the Updated RTOG/NRG and EORTC Guidelines in Patients with High Grade Glioma: A Randomized, Controlled Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). S84–S85.

10.

Mao, Weiqing, et al.. (2022). 99Tc-Methylene Diphosphonate Treatment is Safe and Efficacious for Osteoporosis in Postmenopausal Differentiated Thyroid Cancer Patients Undergoing TSH Suppression: A Three-Center Non-Randomized Clinical Study. SHILAP Revista de lepidopterología. 1 indexed citations

11.

Zaman, Shah, Jiazhi Shen, Shuangshuang Wang, et al.. (2022). Effects of Shading Nets on Reactive Oxygen Species Accumulation, Photosynthetic Changes, and Associated Physiochemical Attributes in Promoting Cold-Induced Damage in Camellia sinensis (L.) Kuntze. Horticulturae. 8(7). 637–637. 9 indexed citations

12.

Yang, Yang, Cheng Chen, Ling Li, et al.. (2021). Environmental eustress modulates β-ARs/CCL2 axis to induce anti-tumor immunity and sensitize immunotherapy against liver cancer in mice. Nature Communications. 12(1). 5725–5725. 52 indexed citations

13.

Wang, Hui, Lin Wang, Xiaocheng Zhou, et al.. (2020). OSCC Exosomes Regulate miR‐210‐3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway. BioMed Research International. 2020(1). 2125656–2125656. 71 indexed citations

14.

Yang, Yingxi, et al.. (2019). A deep learning method to more accurately recall known lysine acetylation sites. BMC Bioinformatics. 20(1). 49–49. 46 indexed citations

15.

Fu, Hongli, Yingxi Yang, Xiaobo Wang, Hui Wang, & Yan Xu. (2019). DeepUbi: a deep learning framework for prediction of ubiquitination sites in proteins. BMC Bioinformatics. 20(1). 86–86. 57 indexed citations

16.

Huang, Chuncui, Shiwei Sun, Jingyu Yan, et al.. (2019). Identification of carbohydrate peripheral epitopes important for recognition by positive-ion MALDI multistage mass spectrometry. Carbohydrate Polymers. 229. 115528–115528. 10 indexed citations

17.

He, Jia, Qiaozhu Zuo, Bo Hu, et al.. (2019). A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Letters. 450. 98–109. 98 indexed citations

18.

Dong, Shanshan, Ranran Wang, Hui Wang, et al.. (2019). HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3. Journal of Experimental & Clinical Cancer Research. 38(1). 110–110. 89 indexed citations

19.

Wang, Hui, Wanhai Xu, Yuying Zhao, et al.. (2019). The correlation of ESCO1 expression with a prognosis of prostate cancer and anti-tumor effect of ESCO1 silencing. Translational Cancer Research. 8(3). 950–961. 1 indexed citations

20.

Ba, Qian, Miao Hao, He Huang, et al.. (2011). Iron Deprivation Suppresses Hepatocellular Carcinoma Growth in Experimental Studies. Clinical Cancer Research. 17(24). 7625–7633. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact